Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain

Bioorganic and Medicinal Chemistry

Volumn 17, Issue 19, 2009, Pages 6983-6992

  Du Cuny, Lei ^a   Song, Zuohe ^b   Moses, Sylvestor ^b   Powis, Garth ^a   Mash, Eugene A ^c   Meuillet, Emmanuelle J ^b   Zhang, Shuxing ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b University of Arizona   (United States)

^c University of Arizona   (United States)

Author keywords

Akt inhibitors; Anticancer drugs; Cell permeability; In silico drug design; Metabolism; Molecular docking scoring; Pleckstrin homology domain; QSAR

Indexed keywords

ALIPHATIC COMPOUND; ANTINEOPLASTIC AGENT; CYTOCHROME P450; PLECKSTRIN; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; COMPUTER MODEL; CONTROLLED STUDY; DRUG BINDING; HUMAN; HUMAN CELL; IN VIVO CULTURE; K NEAREST NEIGHBOR; MOLECULAR DOCKING; PROTEIN DOMAIN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SCORING SYSTEM; SEQUENCE HOMOLOGY;

ANTINEOPLASTIC AGENTS; BLOOD PROTEINS; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; COMPUTER SIMULATION; DRUG DISCOVERY; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MODELS, MOLECULAR; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-AKT; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 69949181643     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2009.08.022     Document Type: Article

References (60)

1. Hennessy B.T., Smith D.L., Ram P.T., Lu Y., and Mills G.B. Nat. Rev. Drug Disc. 4 (2005) 988
2. Manning B.D., and Cantley L.C. Cell 129 (2007) 1261
3. Cheng Jin Q., Lindsley Craig W., Cheng George Z., Yang H., and Nicosia Santo V. Oncogene 24 (2005) 7482
4. Bellacosa A., Testa J.R., Moore R., and Larue L. Cancer Biol. Ther. 3 (2004) 268
5. Breitenlechner C.B., Wegge T., Berillon L., Graul K., Marzenell K., Friebe W.-G., Thomas U., Schumacher R., Huber R., Engh R.A., and Masjost B. J. Med. Chem. 47 (2004) 1375
6. Reuveni H., Livnah N., Geiger T., Klein S., Ohne O., Cohen I., Benhar M., Gellerman G., and Levitzki A. Biochemistry 41 (2002) 10304
7. Yang J., Cron P., Thompson V., Good Valerie M., Hess D., Hemmings Brian A., and Barford D. Mol. Cell 9 (2002) 1227
8. Kumar C.C., and Madison V. Oncogene 24 (2005) 7493
9. Mahadevan D., Powis G., Mash E.A., George B., Gokhale V.M., Zhang S., Shakalya K., Du-Cuny L., Berggren M., Ali M.A., Jana U., Ihle N., Moses S., Franklin C., Narayan S., Shirahatti N., and Meuillet E.J. Mol. Cancer Ther. 7 (2008) 2621
10. Powis G., Aksoy I.A., Melder D.C., Aksoy S., Eichinger H., Fauq A.H., and Kozikowski A.P. Cancer Chemother. Pharmacol. 29 (1991) 95
11. Meuillet E.J., Mahadevan D., Vankayalapati H., Berggren M., Williams R., Coon A., Kozikowski A.P., and Powis G. Mol. Cancer Ther. 2 (2003) 389
12. Meuillet E., Stratton S., Cherukuri D.P., Goulet A.-C., Kagey J., Porterfield B., and Nelson M.A. J. Cell. Biochem. 91 (2004) 443
13. Kozikowski A.P., Sun H., Brognard J., and Dennis P.A. J. Am. Chem. Soc. 125 (2003) 1144
14. Milburn C.C., Deak M., Kelly S.M., Price N.C., Alessi D.R., and van Aalten D.M.F. Biochem. J. 375 (2003) 531
15. Zhang S., Golbraikh A., and Tropsha A. J. Med. Chem. 49 (2006) 2713
16. Zhang S., Kumar K., Jiang X., Wallqvist A., and Reifman J. BMC Bioinf. 9 (2008) 126
17. Bissantz C., Folkers G., and Rognan D. J. Med. Chem. 43 (2000) 4759
18. Warren Gregory L., Andrews C.W., Capelli A.-M., Clarke B., LaLonde J., Lambert Millard H., Lindvall M., Nevins N., Semus Simon F., Senger S., Tedesco G., Wall Ian D., Woolven James M., Peishoff Catherine E., and Head Martha S. J. Med. Chem. 49 (2006) 5912
19. flexx [1.20.1], BioSolveIT GmbH: Sankt Augustin, Germany, 2007.
20. gold [3.2], CCDC: Cambridge, UK, 2007.
21. glide [4.5], Schrodinger: Portland, OR., 2007.
22. Du-Cuny L., Huwyler J., Wiese M., and Kansy M. Eur. J. Med. Chem. 43 (2008) 501
23. Stoner C.L., Troutman M.D., and Laverty C.E. Cancer Drug Des. Disc. (2008) 131
24. Artursson P. Crit. Rev. Ther. Drug Carrier Syst. 8 (1991) 305
25. Kansy M., Senner F., and Gubernator K. J. Med. Chem. 41 (1998) 1007
26. Hou T.J., Zhang W., Xia K., Qiao X.B., and Xu X.J. J. Chem. Inf. Comput. Sci. 44 (2004) 1585
27. Nordqvist A., Nilsson J., Lindmark T., Eriksson A., Garberg P., and Kihlen M. QSAR Comb. Sci. 23 (2004) 303
28. Ekins S., Durst G.L., Stratford R.E., Thorner D.A., Lewis R., Loncharich R.J., and Wikel J.H. J. Chem. Inf. Comput. Sci. 41 (2001) 1578
29. Sun D., Yu L.X., Hussain M.A., Wall D.A., Smith R.L., and Amidon G.L. Curr. Opin. Drug Disc. Dev. 7 (2004) 75
30. Sharaf, M. A.; Illman, D. L.; Kowalski, B. R. Chemical Analysis, Vol. 82: Chemometrics 1986; p 332.
31. metasite [2.7.5], Molecular Discovery Ltd: Pinner, Middlesex, UK, 2007.
32. Cruciani G., Carosati E., De Boeck B., Ethirajulu K., Mackie C., Howe T., and Vianello R. J. Med. Chem. 48 (2005) 6970
33. Moses S., Ali M.A., Zuohe S., Du-Cuny L., Zhou L.L., Lemos R., Ihle N., Sillman G., Zhang S., Mash E.A., Powis G., and Meuillet E. Cancer Res. 69 (2009) 5073
34. http://dtp.nci.nih.gov/branches/dscb/diversity_explanation.html.
35. moe [2006.08], Chemical Computing Group Inc.: Montreal, Quebec, Canada, 2006.
36. Carpten J.D., Faber A.L., Horn C., Donoho G.P., Briggs S.L., Robbins C.M., Hostetter G., Boguslawski S., Moses T.Y., Savage S., Uhlik M., Lin A., Du J., Qian Y.-W., Zeckner D.J., Tucker-Kellogg G., Touchman J., Patel K., Mousses S., Bittner M., Schevitz R., Lai M.-H.T., Blanchard K.L., and Thomas J.E. Nature 448 (2007) 439
37. sybyl [7.3], Tripos: St. Louis, MO, USA, 2007.
38. Dolinsky T.J., Nielsen J.E., McCammon J.A., and Baker N.A. Nucleic Acids Res. 32 (2004) W665
39. Thomas C.C., Deak M., Alessi D.R., and van Aalten D.M.F. Curr. Biol. 12 (2002) 1256
40. Rarey M., Kramer B., Lengauer T., and Klebe G. J. Mol. Biol. 261 (1996) 470
41. Jones G., Willett P., Glen R.C., Leach A.R., and Taylor R. J. Mol. Biol. 267 (1997) 727
42. Friesner Richard A., Banks Jay L., Murphy Robert B., Halgren Thomas A., Klicic Jasna J., Mainz Daniel T., Repasky Matthew P., Knoll Eric H., Shelley M., Perry Jason K., Shaw David E., Francis P., and Shenkin Peter S. J. Med. Chem. 47 (2004) 1739
43. Jain A.N. J. Comput. Aided Mol. Des. 22 (2008) 201
44. GRID [22b], Molecular Discovery Ltd: Oxford, UK, 2008.
45. Pirard B., Brendel J., and Peukert S. J. Chem. Inf. Model. 45 (2005) 477
46. Gleevec FDA Information. http://www.fda.gov/CDER/DRUG/infopage/gleevec/default.htm.
47. Kamath A.V., Wang J., Lee F.Y., and Marathe P.H. Cancer Chemother. Pharmacol. 61 (2008) 365
48. Rakhit A., Pantze M.P., Fettner S., Jones H.M., Charoin J.-E., Riek M., Lum B.L., and Hamilton M. Eur. J. Clin. Pharmacol. 64 (2008) 31
49. Golbraikh A., Shen M., Xiao Z., Xiao Y.-D., Lee K.-H., and Tropsha A. J. Comput. Aided Mol. Des. 17 (2003) 241
50. Zheng W., and Tropsha A. J. Chem. Inf. Comput. Sci. 40 (2000) 185
51. Zhang S., Wei L., Bastow K., Zheng W., Brossi A., Lee K.-H., and Tropsha A. J. Comput. Aided Mol. Des. 21 (2007) 97
52. Mills S.J., Komander D., Trusselle M.N., Safrany S.T., van Aalten D.M.F., and Potter B.V.L. ACS Chem. Biol. 2 (2007) 242
53. Berman H., Henrick K., Nakamura H., and Markley J.L. Nucleic Acids Res. 35 (2007) D301
54. Oloff S., Zhang S., Sukumar N., Breneman C., and Tropsha A. J. Chem. Inf. Model. 46 (2006) 844
55. Zhang S., Golbraikh A., Oloff S., Kohn H., and Tropsha A. J. Chem. Inf. Model. 46 (2006) 1984
56. Boehm H.-J., Boehringer M., Bur D., Gmuender H., Huber W., Klaus W., Kostrewa D., Kuehne H., Luebbers T., Meunier-Keller N., and Mueller F. J. Med. Chem. 43 (2000) 2664
57. Lemmon M.A., Ferguson K.M., and Abrams C.S. FEBS Lett. 513 (2002) 71
58. Lemmon M.A. Nat. Rev. Mol. Cell Biol. 9 (2008) 99
59. Zhang S., and Du-Cuny L. Int. J. Bioinform. Res. Appl. 5 (2009) 269
60. DiNitto J.P., and Lambright D.G. Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 1761 (2006) 850